查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1994761

2026年全球機器人輔助血管內治療系統市場報告

Robotic Assisted Endovascular Systems Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，機器人輔助血管內治療系統的市場規模顯著擴大。預計該市場規模將從2025年的320.1億美元成長到2026年的347.9億美元，複合年成長率為8.7%。過去幾年成長要素包括心血管疾病病例的增加、導管介入治療方法的廣泛應用、介入放射學領域的擴張、微創手術日益受到青睞以及血管成像技術的進步。

預計未來幾年，機器人輔助血管內介入系統市場將維持強勁成長，2030年市場規模將達到489.4億美元，複合年成長率（CAGR）為8.9%。預測期內的成長要素包括：機器人血管實驗室數量的增加、對精準引導介入治療需求的成長、神經血管機器人手術的拓展、遠端手術能力的提升以及醫院對機器人手術室投資的增加。預測期內的主要趨勢包括：機器人導管導航技術的進步、微創血管手術的普及、影像引導機器人平台的擴展、遠端機器人介入治療的廣泛應用以及精準血管控制系統的整合。

預計未來幾年，心血管和神經血管疾病的日益普遍將推動機器人輔助血管內治療系統市場的擴張。心血管和神經血管疾病，包括冠狀動脈疾病、中風和腦動脈瘤，會影響心臟、血管和腦循環，並且仍然是全球主要的死亡和長期殘疾原因。由於人口老化以及肥胖、高血壓和缺乏運動等生活方式相關風​​險因素的增加，心血管和神經血管疾病的發生率正在上升。機器人輔助血管內治療系統能夠在血管內進行高度精確且微創的導航，透過提高複雜血管內手術的準確性、安全性和臨床療效，幫助治療心血管和神經血管疾病。例如，根據總部位於美國的非營利組織美國心臟協會的數據，截至2024年1月，經年齡調整後的心血管疾病死亡率預計為每10萬人233.3人，比2023年的每10萬人224.4人增加4.0%。因此，心血管和神經血管疾病盛行率的上升正在推動機器人輔助血管內治療系統市場的成長。

在機器人輔助血管內治療系統市場中，主要企業正致力於將機器人技術與先進的成像和導航系統（例如全遠端操作的血管內機器人平台）相結合，以提高手術精度、實現複雜的血管內導航並擴大專科醫療服務的覆蓋範圍。全遠端操作的血管內機器人平台是指將即時透視影像與術前CT和MRI資料結合的機器人系統，使臨床醫生能夠在血管內手術過程中透過遠端主機控制機器人對導管和導管導引線的操作。例如，2025年10月，總部位於美國的醫療技術公司Remedy Robotics發布了Remedy N1系統，這是一款旨在支援全遠端介入神經放射學手術的血管內手術機器人平台。該系統旨在提高手術精度和最佳化臨床工作流程，整合了自動化的CT和MRI影像預處理以及用於即時導航的即時透視影像，能夠同時控制多達四個血管內器械，並配備一個帶有安全音訊和影像連接的可攜式操作主機，以支援遠端手術操作。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球機器人輔助血管內治療系統市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 清單：主要原料、資源和供應商
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章：全球市場趨勢與策略

  • 關鍵科技與未來趨勢
    • 人工智慧（AI）和自主人工智慧
    • 自主系統、機器人、智慧運輸
    • 數位化、雲端運算、巨量資料、網路安全
    • 生物技術、基因組學和精準醫療
    • 身臨其境型技術（AR/VR/XR）與數位體驗
  • 主要趨勢
    • 機器人導管導航技術的發展
    • 微創血管治療的廣泛應用
    • 影像引導機器人平台的擴展
    • 遠端機器人介入技術的應用範圍擴大
    • 精密血管控制系統的整合

第5章 終端用戶產業市場分析

  • 醫院
  • 心臟科中心
  • 介入放射科診所
  • 門診手術中心
  • 教學和研究型醫院

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球機器人輔助血管內治療系統市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球機器人輔助血管內治療系統市場規模、對比及成長率分析
  • 全球機器人輔助血管內治療系統市場表現：規模與成長，2020-2025年
  • 全球機器人輔助血管內治療系統市場預測：規模與成長，2025-2030年，2035年預測

第8章：全球市場總規模（TAM）

第9章 市場細分

  • 按組件
  • 硬體、軟體、服務
  • 依產品
  • 機器人導管系統、機器人導管導引線系統、機器人血管成形術系統及其他產品
  • 透過技術
  • 機器人導管系統、人工智慧輔助導航系統、影像引導機器人平台、觸覺回饋系統、自主機器人系統
  • 透過使用
  • 冠狀動脈介入治療、周邊血管介入治療、神經血管介入治療及其他應用
  • 最終用戶
  • 醫院、專科診所、門診手術中心、研究和學術機構以及其他最終用戶
  • 按類型細分：硬體
  • 機器人控制單元、機器人導管系統、導航主機、影像整合模組、手術器械臂
  • 按類型細分：軟體
  • 導航軟體平台、影像處理軟體、手術規劃軟體、資料管理軟體、臨床決策支援軟體
  • 按類型細分：服務
  • 安裝服務、維護和維修服務、培訓和教育服務、系統升級服務

第10章 區域與國別分析

  • 全球機器人輔助血管內治療系統市場：按地區分類，實際結果與預測，2020-2025年、2025-2030年預測、2035年預測
  • 全球機器人輔助血管內治療系統市場：依國家分類，實際結果與預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 機器人輔助血管內治療系統市場：競爭格局及市場佔有率（2024年）
  • 機器人輔助血管內治療系統市場：公司評估矩陣
  • 機器人輔助血管內治療系統市場：公司概況
    • Johnson & Johnson
    • Siemens Healthineers AG
    • Corindus Vascular Robotics Inc.
    • Cordis Corporation
    • MicroPort Scientific Corporation

第37章 其他大型企業和創新企業

  • Hansen Medical Inc., Robocath SAS, Magnetecs Corporation, Cathbot Robot Co. Ltd., EKOS Corporation, Stereotaxis Inc., Imperative Care Inc., WeMed Medical Technology Co. Ltd., Lombard Medical Limited, Endovascular Robotics Inc., SS Innovations International Inc., Visionary Medicare Co. Ltd., Vantis Vascular Inc., Microbot Medical Inc., Sentante Ltd.

第38章：全球市場競爭基準分析與儀錶板

第39章：預計進入市場的Start-Ups

第40章 重大併購

第41章 具有高市場潛力的國家、細分市場與策略

  • 2030年機器人輔助血管內治療系統市場：提供新機會的國家
  • 2030年機器人輔助血管內治療系統市場：充滿新機會的細分市場
  • 2030年機器人輔助血管內治療系統市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第42章附錄

簡介目錄
Product Code: ME3MRAES01_G26Q1

Robotic assisted endovascular systems are advanced medical solutions developed to assist and improve endovascular procedures through highly precise robotic control mechanisms. These systems combine robotic arms, imaging systems, navigation technologies, and operator consoles to support minimally invasive vascular interventions with greater accuracy and stability. They help decrease procedural complexity, enhance safety, and improve overall clinical results.

The major components of robotic-assisted endovascular systems include hardware, software, and services. Hardware refers to the physical robotic devices and instruments used in endovascular procedures, including catheters, guidewires, and angioplasty systems designed to enhance precision, control, and safety. These systems encompass products such as robotic catheter systems, robotic guidewire systems, robotic angioplasty systems, and other devices, utilizing technologies like AI-assisted navigation, imaging-guided robotic platforms, haptic feedback systems, and autonomous robotic systems. They are applied in coronary interventions, peripheral vascular interventions, neurovascular interventions, and other procedures, serving end-users such as hospitals, specialty clinics, ambulatory surgical centers, and research or academic institutions.

Tariffs on robotic control units, catheter robotics hardware, and imaging integration modules are raising procurement costs in the robotic assisted endovascular systems market. Import duties on precision actuators and navigation consoles are impacting system pricing and upgrade cycles. Hospitals in north america and europe that depend on imported robotic platforms are the most affected. Coronary and neurovascular intervention segments see the highest exposure due to advanced hardware requirements. At the same time, tariffs are encouraging regional manufacturing and localized component sourcing. Vendors are building partnerships with domestic device suppliers. This improves supply continuity while increasing short term capital costs.

The robotic assisted endovascular systems market research report is one of a series of new reports from The Business Research Company that provides robotic assisted endovascular systems market statistics, including robotic assisted endovascular systems industry global market size, regional shares, competitors with a robotic assisted endovascular systems market share, detailed robotic assisted endovascular systems market segments, market trends and opportunities, and any further data you may need to thrive in the robotic assisted endovascular systems industry. This robotic assisted endovascular systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The robotic assisted endovascular systems market size has grown strongly in recent years. It will grow from $32.01 billion in 2025 to $34.79 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to increase in cardiovascular disease cases, growth in catheter based interventions, expansion of interventional radiology units, rising preference for minimally invasive surgery, improvements in vascular imaging.

The robotic assisted endovascular systems market size is expected to see strong growth in the next few years. It will grow to $48.94 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to growth in robotic vascular labs, rising demand for precision guided interventions, expansion of neurovascular robotic procedures, increasing remote surgery capabilities, higher hospital investment in robotic suites. Major trends in the forecast period include growth in robotic catheter navigation, rising adoption in minimally invasive vascular procedures, expansion of imaging guided robotic platforms, increasing use of remote robotic intervention, integration of precision vascular control systems.

The increasing prevalence of cardiovascular and neurovascular disorders is anticipated to drive the expansion of the robotic-assisted endovascular systems market in the coming years. Cardiovascular and neurovascular disorders are conditions that impact the heart, blood vessels, and cerebral circulation, including coronary artery disease, stroke, and cerebral aneurysms, and they remain a leading cause of death and long-term disability globally. The incidence of cardiovascular and neurovascular disorders is rising due to aging populations alongside higher rates of lifestyle-related risk factors such as obesity, hypertension, and sedentary behavior. Robotic-assisted endovascular systems aid in managing cardiovascular and neurovascular disorders by enabling highly precise, minimally invasive navigation of blood vessels, thereby enhancing treatment accuracy, safety, and clinical outcomes in complex vascular procedures. For example, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease rose to 233.3 per 100,000 in 2024, an increase of 4.0% from 224.4 per 100,000 in 2023. Consequently, the rising prevalence of cardiovascular and neurovascular disorders is fueling the growth of the robotic-assisted endovascular systems market.

Key companies operating in the robotic assisted endovascular systems market are focusing on integrating robotics with advanced imaging and navigation systems, such as fully remote endovascular robotic platforms, to improve procedural precision, enable complex vascular navigation, and expand access to specialist care. Fully remote endovascular robotic platforms refer to robotic systems that combine real-time fluoroscopic imaging with preoperative CT and MRI data to guide robotic manipulation of catheters and guidewires during endovascular procedures while allowing clinicians to operate from a remote console. For example, in October 2025, Remedy Robotics, a US-based medical technology company, introduced the Remedy N1 System, an endovascular surgical robotic platform designed to support fully remote neurointerventional procedures. It is designed to enhance accuracy and clinical workflow, the system integrates automated CT and MRI image preprocessing with live fluoroscopic imaging for real-time navigation, enables simultaneous robotic control of up to four endovascular devices, and includes a portable operator console with secure audiovisual connectivity to support remote procedural execution.

In October 2025, Remedy Robotics Inc., a US-based healthcare technology firm specializing in robotic-assisted endovascular systems, collaborated with the Australian Stroke Alliance to deploy and implement robotic endovascular systems across hospitals nationwide, improving access to minimally invasive stroke and cardiovascular procedures. Through this collaboration, Remedy Robotics seeks to broaden access to advanced endovascular robotic interventions throughout Australia by integrating its robotic systems into the Stroke Alliance's national clinical network and hospital infrastructure, enhancing procedural efficiency, precision, and patient outcomes in stroke and cardiovascular treatment. The Australian Stroke Alliance is an Australia-based healthcare consortium of clinicians, researchers, and industry participants dedicated to advancing stroke care nationwide.

Major companies operating in the robotic assisted endovascular systems market are Johnson & Johnson, Siemens Healthineers AG, Corindus Vascular Robotics Inc., Cordis Corporation, MicroPort Scientific Corporation, Hansen Medical Inc., Robocath S.A.S., Magnetecs Corporation, Cathbot Robot Co. Ltd., EKOS Corporation, Stereotaxis Inc., Imperative Care Inc., WeMed Medical Technology Co. Ltd., Lombard Medical Limited, Endovascular Robotics Inc., SS Innovations International Inc., Visionary Medicare Co. Ltd., Vantis Vascular Inc., Microbot Medical Inc., Sentante Ltd.

Europe was the largest region in the robotic assisted endovascular systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the robotic assisted endovascular systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the robotic assisted endovascular systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The robotic assisted endovascular systems market consists of sales of robotic arms and positioning mechanisms, imaging and navigation modules, control and operating software licenses, sensors and actuators, and disposable and reusable endovascular instruments. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Robotic Assisted Endovascular Systems Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses robotic assisted endovascular systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for robotic assisted endovascular systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The robotic assisted endovascular systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Component: Hardware; Software; Services
  • 2) By Product: Robotic Catheter Systems; Robotic Guidewire Systems; Robotic Angioplasty Systems; Other Products
  • 3) By Technology: Robotic Catheter Systems; AI-Assisted Navigation Systems; Imaging-Guided Robotic Platforms; Haptic Feedback Systems; Autonomous Robotic Systems
  • 4) By Application: Coronary Interventions; Peripheral Vascular Interventions; Neurovascular Interventions; Other Applications
  • 5) By End-User: Hospitals; Specialty Clinics; Ambulatory Surgical Centers; Research And Academic Institutes; Other End-Users
  • Subsegments:
  • 1) By Hardware: Robotic Control Units; Robotic Catheter Systems; Navigation Consoles; Imaging Integration Modules; Surgical Instrument Arms
  • 2) By Software: Navigation Software Platforms; Imaging Processing Software; Procedure Planning Software; Data Management Software; Clinical Decision Support Software
  • 3) By Services: Installation Services; Maintenance And Repair Services; Training And Education Services; System Upgradation Services
  • Companies Mentioned: Johnson & Johnson; Siemens Healthineers AG; Corindus Vascular Robotics Inc.; Cordis Corporation; MicroPort Scientific Corporation; Hansen Medical Inc.; Robocath S.A.S.; Magnetecs Corporation; Cathbot Robot Co. Ltd.; EKOS Corporation; Stereotaxis Inc.; Imperative Care Inc.; WeMed Medical Technology Co. Ltd.; Lombard Medical Limited; Endovascular Robotics Inc.; SS Innovations International Inc.; Visionary Medicare Co. Ltd.; Vantis Vascular Inc.; Microbot Medical Inc.; Sentante Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Robotic Assisted Endovascular Systems Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Robotic Assisted Endovascular Systems Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Robotic Assisted Endovascular Systems Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Robotic Assisted Endovascular Systems Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Autonomous Systems, Robotics & Smart Mobility
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Biotechnology, Genomics & Precision Medicine
    • 4.1.5 Immersive Technologies (Ar/Vr/Xr) & Digital Experiences
  • 4.2. Major Trends
    • 4.2.1 Growth In Robotic Catheter Navigation
    • 4.2.2 Rising Adoption In Minimally Invasive Vascular Procedures
    • 4.2.3 Expansion Of Imaging Guided Robotic Platforms
    • 4.2.4 Increasing Use Of Remote Robotic Intervention
    • 4.2.5 Integration Of Precision Vascular Control Systems

5. Robotic Assisted Endovascular Systems Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Specialty Cardiac Centers
  • 5.3 Interventional Radiology Clinics
  • 5.4 Ambulatory Surgical Centers
  • 5.5 Academic And Research Hospitals

6. Robotic Assisted Endovascular Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Robotic Assisted Endovascular Systems Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Robotic Assisted Endovascular Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Robotic Assisted Endovascular Systems Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Robotic Assisted Endovascular Systems Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Robotic Assisted Endovascular Systems Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Robotic Assisted Endovascular Systems Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Robotic Assisted Endovascular Systems Market Segmentation

  • 9.1. Global Robotic Assisted Endovascular Systems Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hardware, Software, Services
  • 9.2. Global Robotic Assisted Endovascular Systems Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Robotic Catheter Systems, Robotic Guidewire Systems, Robotic Angioplasty Systems, Other Products
  • 9.3. Global Robotic Assisted Endovascular Systems Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Robotic Catheter Systems, AI-Assisted Navigation Systems, Imaging-Guided Robotic Platforms, Haptic Feedback Systems, Autonomous Robotic Systems
  • 9.4. Global Robotic Assisted Endovascular Systems Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Coronary Interventions, Peripheral Vascular Interventions, Neurovascular Interventions, Other Applications
  • 9.5. Global Robotic Assisted Endovascular Systems Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Research And Academic Institutes, Other End-Users
  • 9.6. Global Robotic Assisted Endovascular Systems Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Robotic Control Units, Robotic Catheter Systems, Navigation Consoles, Imaging Integration Modules, Surgical Instrument Arms
  • 9.7. Global Robotic Assisted Endovascular Systems Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Navigation Software Platforms, Imaging Processing Software, Procedure Planning Software, Data Management Software, Clinical Decision Support Software
  • 9.8. Global Robotic Assisted Endovascular Systems Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Installation Services, Maintenance And Repair Services, Training And Education Services, System Upgradation Services

10. Robotic Assisted Endovascular Systems Market Regional And Country Analysis

  • 10.1. Global Robotic Assisted Endovascular Systems Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Robotic Assisted Endovascular Systems Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Robotic Assisted Endovascular Systems Market

  • 11.1. Asia-Pacific Robotic Assisted Endovascular Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Robotic Assisted Endovascular Systems Market, Segmentation By Component, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Robotic Assisted Endovascular Systems Market

  • 12.1. China Robotic Assisted Endovascular Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Robotic Assisted Endovascular Systems Market, Segmentation By Component, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Robotic Assisted Endovascular Systems Market

  • 13.1. India Robotic Assisted Endovascular Systems Market, Segmentation By Component, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Robotic Assisted Endovascular Systems Market

  • 14.1. Japan Robotic Assisted Endovascular Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Robotic Assisted Endovascular Systems Market, Segmentation By Component, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Robotic Assisted Endovascular Systems Market

  • 15.1. Australia Robotic Assisted Endovascular Systems Market, Segmentation By Component, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Robotic Assisted Endovascular Systems Market

  • 16.1. Indonesia Robotic Assisted Endovascular Systems Market, Segmentation By Component, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Robotic Assisted Endovascular Systems Market

  • 17.1. South Korea Robotic Assisted Endovascular Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Robotic Assisted Endovascular Systems Market, Segmentation By Component, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Robotic Assisted Endovascular Systems Market

  • 18.1. Taiwan Robotic Assisted Endovascular Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Robotic Assisted Endovascular Systems Market, Segmentation By Component, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Robotic Assisted Endovascular Systems Market

  • 19.1. South East Asia Robotic Assisted Endovascular Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Robotic Assisted Endovascular Systems Market, Segmentation By Component, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Robotic Assisted Endovascular Systems Market

  • 20.1. Western Europe Robotic Assisted Endovascular Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Robotic Assisted Endovascular Systems Market, Segmentation By Component, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Robotic Assisted Endovascular Systems Market

  • 21.1. UK Robotic Assisted Endovascular Systems Market, Segmentation By Component, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Robotic Assisted Endovascular Systems Market

  • 22.1. Germany Robotic Assisted Endovascular Systems Market, Segmentation By Component, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Robotic Assisted Endovascular Systems Market

  • 23.1. France Robotic Assisted Endovascular Systems Market, Segmentation By Component, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Robotic Assisted Endovascular Systems Market

  • 24.1. Italy Robotic Assisted Endovascular Systems Market, Segmentation By Component, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Robotic Assisted Endovascular Systems Market

  • 25.1. Spain Robotic Assisted Endovascular Systems Market, Segmentation By Component, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Robotic Assisted Endovascular Systems Market

  • 26.1. Eastern Europe Robotic Assisted Endovascular Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Robotic Assisted Endovascular Systems Market, Segmentation By Component, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Robotic Assisted Endovascular Systems Market

  • 27.1. Russia Robotic Assisted Endovascular Systems Market, Segmentation By Component, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Robotic Assisted Endovascular Systems Market

  • 28.1. North America Robotic Assisted Endovascular Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Robotic Assisted Endovascular Systems Market, Segmentation By Component, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Robotic Assisted Endovascular Systems Market

  • 29.1. USA Robotic Assisted Endovascular Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Robotic Assisted Endovascular Systems Market, Segmentation By Component, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Robotic Assisted Endovascular Systems Market

  • 30.1. Canada Robotic Assisted Endovascular Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Robotic Assisted Endovascular Systems Market, Segmentation By Component, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Robotic Assisted Endovascular Systems Market

  • 31.1. South America Robotic Assisted Endovascular Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Robotic Assisted Endovascular Systems Market, Segmentation By Component, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Robotic Assisted Endovascular Systems Market

  • 32.1. Brazil Robotic Assisted Endovascular Systems Market, Segmentation By Component, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Robotic Assisted Endovascular Systems Market

  • 33.1. Middle East Robotic Assisted Endovascular Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Robotic Assisted Endovascular Systems Market, Segmentation By Component, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Robotic Assisted Endovascular Systems Market

  • 34.1. Africa Robotic Assisted Endovascular Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Robotic Assisted Endovascular Systems Market, Segmentation By Component, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Robotic Assisted Endovascular Systems Market Regulatory and Investment Landscape

36. Robotic Assisted Endovascular Systems Market Competitive Landscape And Company Profiles

  • 36.1. Robotic Assisted Endovascular Systems Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Robotic Assisted Endovascular Systems Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Robotic Assisted Endovascular Systems Market Company Profiles
    • 36.3.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Corindus Vascular Robotics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Cordis Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. MicroPort Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Robotic Assisted Endovascular Systems Market Other Major And Innovative Companies

  • Hansen Medical Inc., Robocath S.A.S., Magnetecs Corporation, Cathbot Robot Co. Ltd., EKOS Corporation, Stereotaxis Inc., Imperative Care Inc., WeMed Medical Technology Co. Ltd., Lombard Medical Limited, Endovascular Robotics Inc., SS Innovations International Inc., Visionary Medicare Co. Ltd., Vantis Vascular Inc., Microbot Medical Inc., Sentante Ltd.

38. Global Robotic Assisted Endovascular Systems Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Robotic Assisted Endovascular Systems Market

41. Robotic Assisted Endovascular Systems Market High Potential Countries, Segments and Strategies

  • 41.1 Robotic Assisted Endovascular Systems Market In 2030 - Countries Offering Most New Opportunities
  • 41.2 Robotic Assisted Endovascular Systems Market In 2030 - Segments Offering Most New Opportunities
  • 41.3 Robotic Assisted Endovascular Systems Market In 2030 - Growth Strategies
    • 41.3.1 Market Trend Based Strategies
    • 41.3.2 Competitor Strategies

42. Appendix

  • 42.1. Abbreviations
  • 42.2. Currencies
  • 42.3. Historic And Forecast Inflation Rates
  • 42.4. Research Inquiries
  • 42.5. The Business Research Company
  • 42.6. Copyright And Disclaimer